BACKGROUND: Up to 75% of patients with Crohn's disease (CD) will have intestinal resection during their life. Most patients will, however, develop postoperative recurrence (endoscopic, clinical or surgical). Several medical and surgical strategies have been attempted to prevent postoperative recurrence. This review evaluates the efficacy of different drug regimens and surgical techniques in the prevention of clinical, endoscopic and surgical postoperative recurrence of CD. METHODS: A literature search for randomized controlled trials on medical or surgical interventions was performed. The endpoints for efficacy were clinical, endoscopic and surgical recurrence. Meta-analyses were performed in case two or more RCTs evaluated the same drug or...
AIM: to investigate whether an endoscopy-based management could prevent the long-term risk of postop...
Postoperative endoscopic recurrence (PER) occurs in nearly 80% of patients 1 year after ileocecal re...
International audienceBACKGROUND:The magnitude of the efficacy of anti-tumour necrosis factor (TNF) ...
Background: Up to 75% of patients with Crohn's disease (CD) will have intestinal resection during th...
AbstractBackgroundUp to 75% of patients with Crohn's disease (CD) will have intestinal resection dur...
Background and Aims: Surgery is an important treatment for Crohn’s disease (CD) but recurrence occur...
BACKGROUND AND METHODS: Risk factors for recurrence of Crohn's disease and the evidence for progress...
Patients with Crohn's disease (CD) often require surgery over their clinical course. However, endosc...
Most patients with Crohn's disease need an intestinal resection, but a majority will subsequently ex...
Background and aims: Patients with Crohn's disease (CD) often require surgery over their clinical co...
Since Crohn's disease patients often undergo surgery and the diseaseoften recurs after surgery, prev...
Surgery still has an important role in the treatment of Crohn’s disease, and more than 70% of patien...
Crohn\u2019s disease patients often suffer recurrence after surgery in a relatively short time. Henc...
At 1 year after a first resection, up to 80% of patients show an endoscopic recurrence, 10-20% have ...
Background Most patients with Crohn's disease need an intestinal resection, but a majority will subs...
AIM: to investigate whether an endoscopy-based management could prevent the long-term risk of postop...
Postoperative endoscopic recurrence (PER) occurs in nearly 80% of patients 1 year after ileocecal re...
International audienceBACKGROUND:The magnitude of the efficacy of anti-tumour necrosis factor (TNF) ...
Background: Up to 75% of patients with Crohn's disease (CD) will have intestinal resection during th...
AbstractBackgroundUp to 75% of patients with Crohn's disease (CD) will have intestinal resection dur...
Background and Aims: Surgery is an important treatment for Crohn’s disease (CD) but recurrence occur...
BACKGROUND AND METHODS: Risk factors for recurrence of Crohn's disease and the evidence for progress...
Patients with Crohn's disease (CD) often require surgery over their clinical course. However, endosc...
Most patients with Crohn's disease need an intestinal resection, but a majority will subsequently ex...
Background and aims: Patients with Crohn's disease (CD) often require surgery over their clinical co...
Since Crohn's disease patients often undergo surgery and the diseaseoften recurs after surgery, prev...
Surgery still has an important role in the treatment of Crohn’s disease, and more than 70% of patien...
Crohn\u2019s disease patients often suffer recurrence after surgery in a relatively short time. Henc...
At 1 year after a first resection, up to 80% of patients show an endoscopic recurrence, 10-20% have ...
Background Most patients with Crohn's disease need an intestinal resection, but a majority will subs...
AIM: to investigate whether an endoscopy-based management could prevent the long-term risk of postop...
Postoperative endoscopic recurrence (PER) occurs in nearly 80% of patients 1 year after ileocecal re...
International audienceBACKGROUND:The magnitude of the efficacy of anti-tumour necrosis factor (TNF) ...